Abstract
Background ARVC is one of the commonest causes of sudden cardiac death amongst people younger than 30 years. Establishing the diagnosis still remains a difficult task, since there is as yet no single non-invasive gold standard test to confirm it. It is therefore essential to identify within a population with suspected ARVC, a subset who will indeed be at a higher risk of developing the disease, and thus at a higher risk of MACE. Imaging criteria that are most commonly studied include right ventricular volumes, ejection fraction and regional wall motion abnormalities. We sought to determine which imaging parameters were better predictors of worse clinical outcomes.
Highlights
arrhythmogenic right ventricular cardiomyopathy (ARVC) is one of the commonest causes of sudden cardiac death amongst people younger than 30 years
It is essential to identify within a population with suspected ARVC, a subset who will be at a higher risk of developing the disease, and at a higher risk of major cardiovascular adverse events (MACE)
Scans were abnormal if RV end-diastolic volume (RVEDV) was increased, or RV ejection fraction (RVEF) was decreased, or late gadolinium enhancement of the LV
Summary
ARVC is one of the commonest causes of sudden cardiac death amongst people younger than 30 years. Establishing the diagnosis still remains a difficult task, since there is as yet no single non-invasive gold standard test to confirm it. It is essential to identify within a population with suspected ARVC, a subset who will be at a higher risk of developing the disease, and at a higher risk of MACE. Imaging criteria that are most commonly studied include right ventricular volumes, ejection fraction and regional wall motion abnormalities. We sought to determine which imaging parameters were better predictors of worse clinical outcomes
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have